NCT01723891View on ClinicalTrials.gov

Study To Compare Safety and Pharmacokinetic Properties of Surfolase Capsule and HT-002-01 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 30, 2012

Conditions
Healthy
Interventions
DRUG

Surfolase capsule

DRUG

HT-002-01

Trial Locations (1)

120-752

Yonsei University Health System, Severance Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Hyundai Pharmaceutical Co., LTD.

INDUSTRY